Liquidia Corp
LQDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819576
In the last 90 days, Liquidia Corp insiders filed 0 open-market purchases and 15 sales; 306 institutions reported holding it in 13F filings for Q3 2026, worth $2.30B in total; no superinvestor holds it.
Holders of 5% or more of LQDA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Liquidia Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 11.90%10.6M shares | – | Oct 18, 20243 filings | Jul 8, 2026 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 9.90%8.66M shares | −0.05 ppfrom 9.95% | Jul 11, 20253 filings | Feb 9, 2026 | SEC |
| Farallon Capital Management, L.L.C. | 13G/A | 9.40%8.37M shares | – | Aug 4, 20261 filing | Aug 4, 2026 | SEC |
| Manning Paul B | 13G/A | 6.50%4.95M shares | – | Feb 16, 20216 filings | Aug 14, 2026 | SEC |
| Iszo Capital LP | 13G | 5.20%4.71M shares | New | Nov 19, 20261 filing | Nov 19, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
32 Schedule 13D and 13G filings on Liquidia Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 20263:56 PM ET | Iszo Capital LPand 3 others | 13G | 5.20%4.71M shares | New | Nov 12, 2026 | SEC |
| Aug 14, 20267:39 PM ET | Manning Paul Band 2 others | 13G/A | 6.50%4.95M shares | – | Jun 30, 2026 | SEC |
| Aug 4, 20268:32 AM ET | Farallon Capital Management, L.L.C.and 28 others | 13G/A | 9.40%8.37M shares | – | Jun 30, 2026 | SEC |
| Jul 8, 202611:12 AM ET | BlackRock, Inc. | 13G/A | 11.90%10.6M shares | – | Jun 30, 2026 | SEC |
| Feb 9, 20268:56 AM ET | Farallon Capital Partners, L.P.and 30 others | 13G/A | 9.90%8.66M shares | −0.05 ppfrom 9.95% | Dec 31, 2025 | SEC |
| Nov 12, 202512:15 PM ET | Farallon Capital Partners, L.P.and 29 others | 13G/A | 9.95%8.57M shares | +1.95 ppfrom 8.00% | Sep 30, 2025 | SEC |
| Jul 11, 20256:32 PM ET | Farallon Capital Partners, L.P.and 29 others | 13G | 8.00%6.83M shares | New | Jul 7, 2025 | SEC |
| Feb 12, 20255:34 PM ET | Legend Aggregator, LPand 1 other | 13G/A | 2.20%1.86M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Manning Paul B | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 18, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Sep 12, 2024 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Sep 4, 2024 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Manning Paul B | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20245:09 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20242:08 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jan 16, 2024 | Legend Aggregator, LP | 13GOld format | – | New | – | SEC |
| Dec 14, 2023 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| May 5, 202311:52 AM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | Manning Paul B | 13G/AOld format | – | – | – | SEC |
| Feb 13, 20239:25 AM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 1, 2023 | Canaan VIII LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Manning Paul B | 13G/AOld format | – | – | – | SEC |
| Jan 5, 2022 | New Enterprise Associates 12, Limited Partnership | 13D/AOld format | – | – | – | SEC |
| Dec 7, 2021 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Apr 15, 2021 | Caligan Partners LP | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | Manning Paul B | 13GOld format | – | New | – | SEC |
| Feb 11, 2021 | Xeraya LT Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2021 | Eshelman Ventures, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2021 | Canaan VIII LP | 13G/AOld format | – | – | – | SEC |
| Jan 28, 2021 | Eshelman Ventures, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2021 | Eshelman Ventures, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
45 notices from officers, directors and other affiliates planning to sell Liquidia Corp shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 20264:11 PM ET | Ramandeep SinghDirector | 8.47K | $560.2K | Sep 14, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 11, 20265:17 PM ET | Ramandeep SinghDirector | 9.02K | $619.2K | Sep 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 21, 20264:37 PM ET | Jason AdairOfficer | 73.6K | $5.23M | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 19, 20264:26 PM ET | Katherine T. Rielly-GauvinDirector | 55.2K | $4.10M | Aug 19, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 19, 20264:04 PM ET | Rajeev SaggarOfficer | 50.0K | $3.70M | Aug 19, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 17, 20265:01 PM ET | Rajeev SaggarOfficer | 29.5K | $2.27M | Aug 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 11, 20264:26 PM ET | Sarah KreppOfficer | 24.9K | $1.62M | Jun 11, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 10, 20264:52 PM ET | Canaan VIII LPDirector | 200.0K | $13.0M | Jun 10, 2026 | UBS Financial Services Inc | SEC |
| Jun 8, 20264:11 PM ET | Canaan VIII LPDirector | 200.0K | $12.8M | Jun 8, 2026 | UBS Financial Services Inc | SEC |
| Jun 4, 20266:38 PM ET | Paul B ManningDirector | 200.0K | $11.1M | Jun 4, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jun 4, 20265:24 PM ET | Canaan VIII LPDirector | 200.0K | $13.0M | Jun 4, 2026 | UBS Financial Services Inc | SEC |
| Jun 1, 20269:56 AM ET | Kirsch Arthur SDirector | 30.0K | $1.84M | Jun 1, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 21, 20265:12 PM ET | Ramandeep SinghDirector | 29.5K | $1.77M | May 21, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 20, 20264:37 PM ET | Serendipity Biopharma LLCDirector · Officer | 106.4K | $6.38M | May 20, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 14, 20264:26 PM ET | Serendipity Biopharma LLCDirector · Officer | 100.0K | $5.76M | May 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 11, 20265:52 PM ET | Canaan VIII LPDirector | 318.9K | $15.9M | May 11, 2026 | UBS Financial Services Inc | SEC |
| May 8, 20264:19 PM ET | Serendipity Biopharma LLCDirector · Officer | 100.0K | $4.23M | May 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 7, 20264:18 PM ET | Serendipity Biopharma LLCDirector · Officer | 25.0K | $1.05M | May 7, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 17, 20264:39 PM ET | Serendipity Biopharma LLCDirector · Officer | 68.8K | $2.85M | Apr 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 16, 20264:13 PM ET | Serendipity Biopharma LLCDirector · Officer | 25.0K | $1.00M | Apr 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 15, 20264:43 PM ET | Serendipity Biopharma LLCDirector · Officer | 24.7K | $957.4K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 15, 20264:42 PM ET | Michael KasetaOfficer | 139.4K | $5.40M | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 14, 20264:37 PM ET | Michael KasetaOfficer | 3.00K | $116.5K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 10, 20264:35 PM ET | Serendipity Biopharma LLCDirector · Officer | 25.0K | $1.01M | Apr 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 10, 20264:34 PM ET | Michael KasetaOfficer | 23.8K | $960.5K | Apr 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the LQDA notices from the last 12 months